Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of TVERP in BPH Patients With Prostate Size ˃30 and ≤80 ml: a Comparison Study Between TVERP With the Plasma Vaporisation Button, Bipolar TURis and HoLEP Treatments.

NCT04398420 is registered in ClinicalTrials.gov with Olympus Surgical Technologies Europe as lead sponsor.

NCT NCT04398420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04398420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of TVERP in BPH Patients With Prostate Size ˃30 and ≤80 ml: a Comparison Study Between TVERP With the Plasma Vaporisation Button, Bipolar TURis and HoLEP Treatments.
Lead sponsor
Olympus Surgical Technologies Europe
Phase
Not applicable
Overall status
Terminated
Start date
August 27, 2020
Completion date
August 1, 2022
Enrollment
29 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hypertrophy